Smooth muscle cell specific ablation of CXCL12 downregulates endothelial CXCR7 leading to defective coronary arteries and cardiac hypertrophy

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Moritz Messner

Innsbruck Medical University, Innsbruck (Austria)

202 More presentations in this session

Presentation thumbnail

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Doctor T. Yamamoto (Tokyo, JP)

Abstract Slides

Presentation thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Doctor C. Lo (Miaoli, TW)

Abstract Slides

Presentation thumbnail

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Professor I. Andreadou (Athens, GR)

Abstract Slides

Presentation thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Associate Professor G. Rigatelli (Rovigo, IT)

Abstract Slides

Presentation thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Doctor M. Gonotkov (Syktyvkar, RU)

Abstract Slides

Access the full session

Session thumbnail

Basic science e-posters

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Webinar

Elevating cardiac expertise: practical approach to left ventricular hypertrophy phenotypes assessment

Congress Presentation

Multimodality imaging in hypertrophied hearts

Congress Presentation

Contemporary treatment of hypertrophic cardiomyopathy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources